2‐Isoxazoline derivatives. Part I. A base‐promoted fragmentation of 2‐isoxazolines
Copyright policy ) Giorgio Bianchi; Remo Gandolfi; Paolo Grünanger;
2‐Isoxazoline derivatives. Part I. A base‐promoted fragmentation of 2‐isoxazolines
AbstractThe action of bases on 3‐aryl (or alkyl)‐5‐acyl‐2‐isoxazolines has been shown to give rise to the corresponding aromatic (or aliphatic) nitriles and α‐diketones by cleavage of the O‐N and C3C4 bonds of the heterocyclic ring. This fragmentation reaction has been extended to other 2‐isoxazolines substituted in the 5‐position with electron‐attracting groups.
- University of Pavia Italy
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 24
Average
Top 10%
Average
This action will publish the selected files and record in Zenodo. Are you sure you want to proceed?